Inhibikase Therapeutics, Inc.
IKT
$2.41
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.66% | -4.70% | 131.19% | -11.80% | -5.92% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.31% | 298.18% | -46.38% | -9.70% | -27.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 347.51% | -47.43% | 65.49% | 31.71% | 508.00% |
| Total Current Assets | -5.71% | -4.40% | 129.33% | -11.55% | -5.70% |
|
|
|||||
| Total Current Assets | -5.71% | -4.40% | 129.33% | -11.55% | -5.70% |
| Net Property, Plant & Equipment | -- | -- | -- | -100.00% | -49.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.69% | 5.54% | 3.52% | -- | -- |
| Total Assets | -5.62% | -4.34% | 127.66% | -10.42% | -5.76% |
|
|
|||||
| Total Accounts Payable | -37.52% | 37.06% | 86.64% | -77.05% | 59.78% |
| Total Accrued Expenses | 124.70% | 1.06% | 11.62% | 16.23% | -10.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -49.33% |
| Total Finance Division Other Current Liabilities | -- | -- | 26.54% | -16.93% | -10.96% |
| Total Other Current Liabilities | -- | -- | 26.54% | -16.93% | -10.96% |
| Total Current Liabilities | 79.62% | -31.19% | 23.96% | -23.90% | 2.91% |
|
|
|||||
| Total Current Liabilities | 79.62% | -31.19% | 23.96% | -23.90% | 2.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 79.62% | -31.19% | 23.96% | -23.90% | 2.91% |
|
|
|||||
| Common Stock & APIC | 1.64% | 3.53% | 55.57% | 2.41% | 2.19% |
| Retained Earnings | -12.32% | -11.48% | -9.80% | -10.11% | -9.17% |
| Treasury Stock & Other | -176.81% | -220.64% | 619.05% | -44.83% | -190.00% |
| Total Common Equity | -8.53% | -3.06% | 137.18% | -8.94% | -6.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.53% | -3.06% | 137.18% | -8.94% | -6.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.53% | -3.06% | 137.18% | -8.94% | -6.62% |
|
|
|||||